Potential cost-effectiveness of one-time screening for lung cancer (LC) in a high risk cohort

被引:66
作者
Marshall, D
Simpson, KN
Earle, CC
Chu, CW
机构
[1] Bayer Diagnost, Emeryville, CA USA
[2] Med Univ S Carolina, Charleston, SC 29425 USA
[3] Dana Farber Canc Inst, Boston, MA 02115 USA
关键词
cost-effectiveness analysis; lung cancer screening; helical computed-tomography; Early Lung Cancer Action Project;
D O I
10.1016/S0169-5002(00)00239-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The development of low-dose helical computed-tomography (CT) scanning to detect nodules as small as a few mm has sparked renewed interest in lung cancer (LC) screening. The objective of this study was to assess the potential health effects and cost-effectiveness of a one-time low-dose helical CT scan to screen for LC. We created a decision analysis model using baseline results from the Early Lung Cancer Action Project (ELCAP); Surveillance, Epidemiology and End Results (SEER) registry public-use database: screening program costs estimated from 1999 Medicare reimbursement rates: and annual costs of managing cancer and non-cancer patients from Riley et al. (1995) [Med Care 1995:33(8):828-841] and Taplin et al. (1995) [J Nail Cancer Inst 1995:87(6):417-26], The main outcome measures included years of life, cost estimates of baseline diagnostic screening and Follow up, and cost-effectiveness of screening. We found that in a very high-risk cohort (LC prevalence of 2.7%) of patients between 60 and 74 years of age. a one-time screen appears to be cost-effective at $5940 per life year saved. In a lower risk general population of smokers (LC prevalence of 0.7%), a one-time screen appears to be cost-effective at $23 100 per life year. Even when a lead-time bias of 1 year is incorporated into the model for a low risk population, the cost-effectiveness is estimated at $58 183 per life year. Based on the assumptions embedded in this model, one-time screening of elderly high-risk patients for LC appears to be cost-effective. (C) 2001 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:227 / 236
页数:10
相关论文
共 30 条
  • [11] Early Lung Cancer Action Project: overall design and findings from baseline screening
    Henschke, CI
    McCauley, DI
    Yankelevitz, DF
    Naidich, DP
    McGuinness, G
    Miettinen, OS
    Libby, DM
    Pasmantier, MW
    Koizumi, J
    Altorki, NK
    Smith, JP
    [J]. LANCET, 1999, 354 (9173) : 99 - 105
  • [12] Prognostic assessment of 1310 patients with non-small-cell lung cancer who underwent complete resection from 1980 to 1993
    Inoue, K
    Sato, M
    Fujimura, S
    Sakurada, A
    Takahashi, S
    Usuda, K
    Kondo, T
    Tanita, T
    Handa, M
    Saito, Y
    Sagawa, M
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1998, 116 (03) : 407 - 411
  • [13] Peripheral lung cancer: Screening and detection with low-dose spiral CT versus radiography
    Kaneko, M
    Eguchi, K
    Ohmatsu, H
    Kakinuma, R
    Naruke, T
    Suemasu, K
    Moriyama, N
    [J]. RADIOLOGY, 1996, 201 (03) : 798 - 802
  • [14] The influence of lung cancer mass screening on surgical results
    Koike, T
    Terashima, M
    Takizawa, T
    Haga, M
    Kurita, Y
    Yokoyama, A
    Misawa, H
    [J]. LUNG CANCER, 1999, 24 (02) : 75 - 80
  • [15] Koike T, 1999, Jpn J Thorac Cardiovasc Surg, V47, P313
  • [16] Lung cancer mortality in the Mayo Lung Project: Impact of extended follow-up
    Marcus, PM
    Bergstralh, EJ
    Fagerstrom, RM
    Williams, DE
    Fontana, R
    Taylor, WF
    Prorok, PC
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (16) : 1308 - 1316
  • [17] Miettinen OS, 2000, CAN MED ASSOC J, V162, P1431
  • [18] Screening for lung cancer
    Miettinen, OS
    [J]. RADIOLOGIC CLINICS OF NORTH AMERICA, 2000, 38 (03) : 479 - +
  • [19] Revisions in the International System for Staging Lung Cancer
    Mountain, CF
    [J]. CHEST, 1997, 111 (06) : 1710 - 1717
  • [20] *NAT CANC I, 1999, EST NEW CANC CAS DEA